QQQ $ 445.88 $ 2.85 (0.64 %)
DIA $ 395.58 $ 1.12 (0.28 %)
SPY $ 523.16 $ 2.39 (0.46 %)
TLT $ 90.86 $ 0.51 (0.56 %)
GLD $ 218.12 $ 1.83 (0.85 %)
$ 1.0E-6
-- x --
-- x --
-- - --
$ 0.00 - $ 0.50
211
na
277.31M
$ -2.78
$ 6.25
TBD
na
na ($ 0.02)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-08-2024 03-31-2024 10-Q
2 03-11-2024 12-31-2023 10-K
3 11-13-2023 09-30-2023 10-Q
4 08-11-2023 06-30-2023 10-Q
5 05-11-2023 03-31-2023 10-Q
6 02-22-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 08-15-2022 06-30-2022 10-Q
9 05-13-2022 03-31-2022 10-Q
10 02-25-2022 12-31-2021 10-K
11 11-03-2021 09-30-2021 10-Q
12 08-16-2021 06-30-2021 10-Q
13 05-07-2021 03-31-2021 10-Q
14 03-05-2021 12-31-2020 10-K
15 11-06-2020 09-30-2020 10-Q
16 08-07-2020 06-30-2020 10-Q
17 05-08-2020 03-31-2020 10-Q
18 03-06-2020 12-31-2019 10-K
19 11-07-2019 09-30-2019 10-Q
20 08-14-2019 06-30-2019 10-Q
21 05-10-2019 03-31-2019 10-Q
22 02-27-2019 12-31-2018 10-K
23 11-02-2018 09-30-2018 10-Q
24 08-03-2018 06-30-2018 10-Q
25 05-11-2018 03-31-2018 10-Q
26 02-27-2018 12-31-2017 10-K
27 11-03-2017 09-30-2017 10-Q
28 08-04-2017 06-30-2017 10-Q
29 05-05-2017 03-31-2017 10-Q
30 03-03-2017 12-31-2016 10-K
31 11-04-2016 09-30-2016 10-Q
32 08-05-2016 06-30-2016 10-Q
33 05-06-2016 03-31-2016 10-Q
34 02-26-2016 12-31-2015 10-K
35 10-30-2015 09-30-2015 10-Q
36 07-31-2015 06-30-2015 10-Q
37 05-01-2015 03-31-2015 10-Q
38 02-27-2015 12-31-2014 10-K
39 10-31-2014 09-30-2014 10-Q
40 08-01-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-downgrades-imv-to-neutral

HC Wainwright & Co. analyst Joseph Pantginis downgrades IMV (NASDAQ:IMV) from Buy to Neutral.

Core News & Articles

IMV Inc. (the "Company" or "IMV") (NASDAQ:IMV, TSX:IMV), a clinical-stage biopharmaceutical Company developing ...

 why-bed-bath--beyond-shares-are-trading-lower-by-23-here-are-20-stocks-moving-premarket

Gainers

Core News & Articles

IMV Inc. ("IMV" or the "Company") (NASDAQ:IMV, TSX:IMV), a clinical-stage company developing a portfolio of imm...

 hc-wainwright--co-reiterates-buy-on-imv---1-for-10-reverse-stock

HC Wainwright & Co. analyst Joseph Pantginis reiterates IMV (NASDAQ:IMV) with a Buy, 1-for-10 reverse stock

 earnings-scheduled-for-march-15-2023

Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly earnings at $0.04 per share...

 imvs-earnings-a-preview
IMV's Earnings: A Preview
03/14/2023 18:02:47

 stocks-that-hit-52-week-lows-on-tuesday

  On Tuesday, 93 companies set new 52-week lows.

 stocks-that-hit-52-week-lows-on-friday

  On Friday, 135 companies reached new 52-week lows.

 why-top-ships-are-trading-lower-by-45-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Gainers Amesite Inc. (NASDAQ: AMST) shares jumped 123% to $0.6284 after the company announced GPT-3 powered functionality to...

 stocks-that-hit-52-week-lows-on-tuesday

  During Tuesday, 40 stocks hit new 52-week lows.

 why-frequency-therapeutics-are-trading-lower-by-82-here-are-other-stocks-moving-in-mondays-mid-day-session

Gainers Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) shares jumped 120.5% to $1.02 after jumping over 72% on Friday.

 stocks-that-hit-52-week-lows-on-monday

  On Monday, 42 companies hit new 52-week lows.

 hc-wainwright--co-reiterates-buy-on-imv-maintains-65-price-target

HC Wainwright & Co. analyst Joseph Pantginis reiterates IMV (NASDAQ:IMV) with a Buy and maintains $65 price target.

 imv-presents-positive-initial-results-from-the-mvp-s-phase-2b-vitalize-trial

The company announced positive preliminary data from the VITALIZE Phase 2B trial evaluating its lead DPX product, maveropepimut...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION